Facial Plastic Surgery Clinics of North America北美面部整形外科临床
Facial Plastic Surgery Clinics of North America(英文缩写 FACIAL PLAST SURG CL),ISSN 1064-7406,eISSN 1558-1926,中文译名:北美面部整形外科临床 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-10-01 至 2026-09-30，按本站收录文献的发表日期统计。
期刊介绍
历年影响因子趋势
| JCR 数据年份 | 影响因子 | JCR 分区 |
|---|---|---|
| 2021 | 1.875 | Q3 |
| 2022 | 1.300 | Q4 |
| 2023 | 1.900 | Q2 |
| 2024 | 1.900 | Q2 |
| 2025 | 1.900 | Q2 |
Facial Plastic Surgery Clinics of North America 最新收录文献
-
1. Nutritional Biologics for Skin and Hair.
PMID:日期:2026-07-02Skin and hair quality directly impact facial plastic surgery outcomes, influencing wound healing, scar quality, pigmentation, inflammation, and perioperative telogen effluvium. This review summarizes the nutritional biologics-dietary nutrients and bioactive compounds with mechanistic and clinical relevance to aesthetic practice. Vitamins A and C support keratinocyte differentiation and collagen hydroxylation; vitamin D and zinc contribute to barrier immunity, antimicrobial peptides, and tissue repair. A structured nutritional assessment and targeted correction of deficiencies, paired with a low-glycemic, antioxidant-rich dietary pattern, offers a practical, low-risk strategy to optimize perioperative recovery and long-term maintenance after facial aesthetic and reconstructive procedures.
-
2. The Role of Human Placental Mesenchymal Stem Cell Derived Exosomes in Wound Healing and Scar Therapy.
PMID:日期:2026-06-18Exosomes are a subtype of extracellular vesicles, critical for intercellular communication. They are released from a cell via exocytosis, after which they travel through the extracellular fluid until they reach a target cell. Research in the fields of cellular medicine, regenerative and stem cell therapy continues to grow exponentially. Deciphering the biological properties of mesenchymal stem cells-exosomes as cell-free therapeutic tools is important for wound healing and cutaneous regeneration. The future is also bright for genetically engineering exosomes for targeted diagnostic and therapeutic applications.
-
3. Direct Injection of Stem Cells and Differentiated Cells: European Experience and Dubai Perspective.
PMID:日期:2026-06-12This article reviews the clinical application of direct injection of stem cells and differentiated cells, comparing established European experience with the rapidly evolving regenerative medicine landscape in Dubai. It highlights the strongest evidence in orthopedic applications, outlines current limitations in standardization and long-term outcomes, and examines emerging technologies such as exosomes and engineered cellular therapies. Differences in regulatory frameworks and clinical adoption are discussed, emphasizing the need for continued evidence-based integration and ethical oversight in the expansion of regenerative medicine.
-
4. Bioelectric Modulation as a Systems-Level Adjunct to Regenerative Therapies in Facial Plastic Surgery and Hair Restoration.
4. 生物电调节作为面部整形手术和毛发修复中再生疗法的系统级辅助手段PMID:日期:2026-06-12Regenerative strategies in facial plastic surgery increasingly incorporate platelet-rich fibrin, platelet-rich plasma, fat grafting, and emerging biologic agents. Despite widespread adoption, outcomes remain variable, in part due to limited control of upstream processes such as perfusion, extracellular matrix remodeling, and stem cell niche stability. To review the mechanistic basis and emerging clinical evidence supporting bioelectric modulation as a systems-level regulator of regenerative pathways relevant to facial rejuvenation, wound healing, and hair restoration. Bioelectric modulation represents a plausible investigational adjunct to biologic therapies in facial plastic surgery. Further studies are required to define efficacy, optimize treatment parameters, and evaluate long-term safety.
-
5. Clinical Applications of Pure Recombinant Human Platelet-Derived Growth Factor BB in Esthetic Medicine and Plastic Surgery.
PMID:日期:2026-06-11Goals in plastic surgery and aesthetic medicine include minimizing healing complications, optimize aesthetic outcomes and improve patient satisfaction. Platelet-derived growth factor BB (PDGF-BB) is among the most potent natural activators of healing. A pharmaceutical copy of natural PDGF-BB, (rhPDGF-BB or pure PDGF) is the active ingredient in four US Food and Drug Administration-approved therapies to stimulate healing of skin, mucosa, gingivae or bone. Here we describe the mechanism of action and clinical uses of off-the-shelf pure PDGF in plastic surgery and aesthetic medicine as a post-treatment adjunct to enhance patient satisfaction.
-
6. US Food and Drug Administration and Regulation Issues for Biologics: The Sands Are Shifting.
PMID:日期:2026-06-08Stem cell clinics and stem cell use are arguably subject to regulatory oversight at multiple levels including the US Food and Drug Administration (FDA), offices of attorney generals, and state medical licensing boards. Such regulatory oversight has been enforced unevenly. Two high profile appellate court cases propelled by the FDA, Department of Justice criminal prosecutions, and a US Supreme Court decision have reshuffled the deck, auguring over the next several years paradoxically for both more stringent enforcement and less enforcement.
-
7. A New Frontier of Cosmetic Technology: Modified mRNA for Personalized Applications.
PMID:日期:2026-06-08This is a review of modified mRNA (mmRNA) science and a description of a novel application of mmRNA for the creation of personalized cosmetic products.
-
8. Photobiomodulation and Biological Pathways in Skin Regeneration and Rejuvenation: Light and Biological Activation of Skin Improvement.
8. 皮肤再生和再生中的光生物调节和生物途径：皮肤改善的光和生物激活PMID:日期:2026-06-08Photobiomodulation harnesses visible and near-infrared wavelengths to modulate mitochondrial energetics and transcriptional programs that orchestrate wound repair, immune homeostasis, angiogenesis, and organized extracellular matrix remodeling. In parallel, topical or intradermal biological interventions (including exosomes, platelet-rich plasma and platelet-rich fibrin, polydeoxyribonucleotides, polynucleotides, recombinant growth factors, and bioactive peptides) deliver molecular cargo that stimulates collagen synthesis, elastin assembly, and barrier restoration. Fractional ablative and non-ablative laser systems, along with mechanical and energy-based microneedling platforms, overcome the stratum corneum barrier to facilitate substantive dermal penetration of these agents through laser-assisted drug delivery (or device-assisted drug delivery).
-
9. Evaluation of Emerging Treatments that Activate Stem Cell Pathways for Hair Growth.
9. 评估激活干细胞途径促进头发生长的新兴治疗方法PMID:日期:2026-06-08Today there is a growing shift in the paradigm from restorative medicine to regenerative medicine using regenerative biologics. Additional research is occurring to help solve some of the challenges of hair regeneration. While there is not a one size fits all formula for patients, further study of biologics including PRP, exosomes, PDGF, organoids, will continue to refine approaches and improve outcomes, a thorough evaluation of these approaches with consideration of not only the components but also the delivery method is key to achieving a high degree of efficacy while maintaining patient safety at the same time.
-
10. Defensins.
PMID:日期:2026-06-08This review summarizes current understanding of defensin peptides in skin and hair rejuvenation. It draws on preclinical animal models, mechanistic studies, and human clinical trials, including data on α-defensin and β-defensin formulations. Defensins are discussed in the context of regenerative peptides, growth factor-based cosmeceuticals, extracellular vesicles, safety, regulatory considerations, and heterochronic parabiosis. The goal is to provide facial plastic surgeons and aesthetic clinicians with a practical, evidence-based overview of defensin therapy and its potential integration into regenerative aesthetic practice.